학술논문
Masitinib for mild-to-moderate Alzheimer’s disease: results from a randomized, placebo-controlled, phase 3, clinical trial
Document Type
Article
Author
Source
In: Alzheimer's Research and Therapy . (Alzheimer's Research and Therapy, December 2023, 15(1))
Subject
Language
English
ISSN
17589193